Literature DB >> 32104641

Chryseobacterium indologenes, an Emerging Bacteria: A Case Report and Review of Literature.

Dora E Izaguirre-Anariba1, Vel Sivapalan1.   

Abstract

Chryseobacterium indologenes are aerobic, Gram negative, nonfermentative rods that are intrinsically multi-drug resistant. Reported infections include bacteremia, pneumonia, meningitis, myositis, keratitis, and indwelling devices. We present the clinical course of a 52-year-old African male with a medical history of end stage renal disease (ESRD) in hemodialysis with multiple episodes of central line-associated bloodstream infections (CLABSI) presenting with symptoms of chills, malaise, and localized erythema on insertion site of permacath. Blood cultures obtained from catheter showed C. indologenes. Successful response was obtained with piperacillin/tazobactam based on sensitivity and removal of indwelling catheter. Given the increase in the number of cases reported in the literature, guidelines for the management of this pathogen should be considered.
Copyright © 2020, Izaguirre-Anariba et al.

Entities:  

Keywords:  bacteremia; c. indologenes; central line-associated infections (clabsi); multi-drug resistant bacteria

Year:  2020        PMID: 32104641      PMCID: PMC7032597          DOI: 10.7759/cureus.6720

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  9 in total

1.  Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor.

Authors:  George B Christakis; Stavroula P Perlorentzou; Irene Chalkiopoulou; Athanasios Athanasiou; Nikolas J Legakis
Journal:  J Clin Microbiol       Date:  2005-04       Impact factor: 5.948

Review 2.  Chryseobacterium indologenes: an emerging infection in the USA.

Authors:  Ridhwi Mukerji; Radhika Kakarala; Susan Jane Smith; Halina G Kusz
Journal:  BMJ Case Rep       Date:  2016-04-06

3.  Flavobacterium indologenes bacteremia: clinical and microbiological characteristics.

Authors:  P R Hsueh; T R Hsiue; J J Wu; L J Teng; S W Ho; W C Hsieh; K T Luh
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

4.  A catheter-related bloodstream infection caused by Chryseobacterium indologenes successfully treated with antibiotic-lock rescue therapy.

Authors:  Marta Corbella; Micaela Brandolini; Patrizia Cambieri; Nunzia Decembrino; Michele Pagani; Andrea Bottazzi; Alba Muzzi; Marco Zecca; Bianca Mariani; Piero Marone
Journal:  New Microbiol       Date:  2017-07-04       Impact factor: 2.479

5.  Clinical and epidemiological features of Chryseobacterium indologenes infections: analysis of 215 cases.

Authors:  Fu-Lun Chen; Giueng-Chueng Wang; Sing-On Teng; Tsong-Yih Ou; Fang-Lan Yu; Wen-Sen Lee
Journal:  J Microbiol Immunol Infect       Date:  2012-09-27       Impact factor: 4.399

6.  Urinary tract infection by Chryseobacterium indologenes.

Authors:  G Bhuyar; S Jain; H Shah; V K Mehta
Journal:  Indian J Med Microbiol       Date:  2012 Jul-Sep       Impact factor: 0.985

7.  Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).

Authors:  Jeffrey T Kirby; Helio S Sader; Timothy R Walsh; Ronald N Jones
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

8.  Bacteremia by Chryseobacterium indologenes in a Patient with Lung Cancer: A Clinical and Microbiological Investigation.

Authors:  Gitali Bhagawati; Ashutosh Bhardwaj; Rekha Sajikumar; Sukhwinder Pal Singh; Sanjeev Prajapati
Journal:  Indian J Crit Care Med       Date:  2019-03

9.  Pleural effusion due to Chryseobacterium indologenes: Case report and review of literature.

Authors:  Nazneen Arif; Swati Khullar; Ratnesh Kumar; Shiv Kumar Choudhary; Arti Kapil; Benu Dhawan
Journal:  J Lab Physicians       Date:  2019 Jul-Sep
  9 in total
  5 in total

1.  Metagenomic analysis of MWWTP effluent treated via solar photo-Fenton at neutral pH: Effects upon microbial community, priority pathogens, and antibiotic resistance genes.

Authors:  Pâmela B Vilela; Rondon P Mendonça Neto; Maria Clara V M Starling; Alessandra da S Martins; Giovanna F F Pires; Felipe A R Souza; Camila C Amorim
Journal:  Sci Total Environ       Date:  2021-08-12       Impact factor: 7.963

2.  Chryseobacterium Indologenes Sepsis and Acute Renal Failure Secondary to Abdominal Compartment Syndrome in a Confirmed COVID-19 Patient.

Authors:  Alejandro José Quiroz Alfaro; Iván Javier Rodríguez Acosta; Mayumi Tanaka Takegami; Liliana Michelle Bracho Maya; Roberto Eduardo Quiroz Simanca
Journal:  Case Rep Crit Care       Date:  2022-04-14

3.  Whole genome sequencing of the multidrug-resistant Chryseobacterium indologenes isolated from a patient in Brazil.

Authors:  Marcelo Silva Folhas Damas; Roumayne Lopes Ferreira; Emeline Boni Campanini; Gabriela Guerrera Soares; Leslie Camelo Campos; Pedro Mendes Laprega; Andrea Soares da Costa; Caio César de Melo Freire; André Pitondo-Silva; Louise Teixeira Cerdeira; Anderson Ferreira da Cunha; Maria-Cristina da Silva Pranchevicius
Journal:  Front Med (Lausanne)       Date:  2022-07-28

4.  Chryseobacterium indologenes Ventilator-Associated Pneumonia in an Elderly Patient: A Case Report.

Authors:  Mahdi M Fadlallah; Darine M Kharroubi; Zeinab Zeineddine; Sarah M Salman
Journal:  Cureus       Date:  2022-07-28

5.  The Burkholderia cenocepacia Type VI Secretion System Effector TecA Is a Virulence Factor in Mouse Models of Lung Infection.

Authors:  Nicole A Loeven; Andrew I Perault; Peggy A Cotter; Craig A Hodges; Joseph D Schwartzman; Thomas H Hampton; James B Bliska
Journal:  mBio       Date:  2021-09-28       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.